SYSMEX CORP

Sysmex Corporation develops, manufactures, and sells diagnostic instruments, reagents, and software in Japan. Products include hematology instruments, urine particle analyzers, blood coagulation analyzers, and immunochemistry systems. The company also offers flow cytometers, cancer lymph node metastasis testing systems, and lab assay services. Additionally, it provides software for diagnostic information systems and IT solutions. The company serves national and public hospitals, private hospitals, universities, research institutes, and other medical institutions. It exports products to approximately 190 countries.

Overview

Sector

Medical Devices

Target Price

1223.7 JPY

Current Price

2477.0 JPY

Potential

-51%

Strengths

The company has low debt. Net Debt to EBITDA Ratio is -0.20 and it is lower than the sector mean.
The company has high returns. ROIC (16.70%) is higher than the sector mean (2.97%).
EV/EBIT (18.62) is lower than the sector mean.
Strong EBITDA Margin of 24.57%.

Weaknesses

With a depreciation Potential of -51.25%, based on our fundamental analysis, it suggests the stock may be overvalued.

Key Financial Data

Indicator	Value
PER	28.8
EV/EBITDA	12.2
Price/Free Cash Flow'	40.3
ROIC	16.7%
Net Debt/EBITDA	-0.2